Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin

Anticancer Research

Volumn 18, Issue 4 C, 1998, Pages 2945-2951

  Raaphorst, G P ^a   Mao, J ^a   Yang, H ^a   Goel, R ^a   Niknafs, B ^a   Shirazi, F H ^a   Yazdi, H M ^a   Rippstein, P ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Apoptosis; Cisplatin; Glioma; Ovarian carcinoma

Indexed keywords

AGAROSE; ANTINEOPLASTIC AGENT; CISPLATIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTRON MICROSCOPY; EVALUATION AND FOLLOW UP; GLIOMA CELL; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MELANOMA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; EVALUATION STUDIES; FEMALE; GLIOMA; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; NEOPLASMS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031812461     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Piver MS: Ovarian carcinoma, A decade of progress. Cancer 54: 2706-2715, 1984.
2. Sledge GW: Cisplatin and platinum analogues in breast cancer. Seminars in Oncol 19: 78-82, 1992.
3. Keizer HJ, Karim ABMF, Njo KH et al: Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in com, bination with radiotherapy. Radiotherapy and Oncology 1: 227-234, 1984.
4. Kuske RR, Perez CA, Grigsby PW et al: Phase I/II Study of Definitive Radiotherapy and Chemotherapy (Cisplatin and 5-Fluorouracil) for Advanced or Recurrent Gynecologic Malignancies. Am J Clin Oncol 12: 467-473, 1989.
5. Jakse G, Frommhold H, Morberger H: Combined cisplatin and radiation therapy in patients with stages pT3 and pT4 bladder cancer. A pilot study. J Urol 129: 502-504, 1983.
6. Schaake-Koning C, Bartelink C, Adema BH et al: Radiotherapy and cis-diamminedichloroplatinum(II) as a combined treatment modality for inoperable non-small cell lung cancer. Int J Radiat One 12: 379-383, 1986.
7. Raaphorst GP, Yang DP, Grewaal D et al: Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncology Reports 2: 1037-1043, 1995.
8. Douple EB: Interaction between cisplatin coordination complexes and radiaiton. In: Hill BT, Bellamy AS. (eds): Antitumour drugradiation interactions. Boca Raton, Florida, CRC Press 1990, pp 171 190.
9. Dritschilo A, Piro A, Kelman AD: The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. Int J Radiat Oncol 5: 1345-1349, 1979.
10. Raaphorst GP, Wang G, Ng CE: Radiosensitization by cisplatin treatment in cisplatin resistant and sensitive human ovarian carcinoma cell lines. Int J Oncol 7: 325-330, 1995.
11. Konings AWT, Hettinga JVE, Lemstra W et al: Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hypertherm 9: 553-562, 1993.
12. Masuda H, Tanaka T, Kido A et al: Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer J 4: 283-287, 1991.
13. Herman TS, Teicher BA, Cathcart FNS et al: Effect of hyperthermia on diaminedichloroplatinum (II) and pt(Rh-123) in a human squamous carcinoma cell line and a cisplatin resistant subline. Cancer Res 48: 5101-5105, 1988.
14. Raaphorst GP, Chabot P, Doja S, Wilkins D, Stewart D and Ng CE: Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hypertherm 129: 211-222, 1996.
15. Raaphorst GP, Yang H, Wilkins DE et al: Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines. Int J Hypertherrnia 12(6): 801-812, 1996.
16. Raaphorst GP, Miao J and Ng CE: Cisplatin and mild hypertherrnia in radiosensitization to low dose rate irradiation in human ovarian carcionma cells. Anti Cancer Res In press 1997.
17. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (Apoptosis)by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
18. Ormerod MG, O'Neill C, Robertson D, Kelland LR and Harrop KR: Cis-diamminedichloroplatinum (II) induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 37: 463-471, 1996.
19. Ormerod MG, Orr RM and Peacock JH: The role of apoptosis in cell killing by cisplatin: a flowcytometric study. Br J Cancer 69: 93-100, 1994.
20. Meyn RE: Apoptosis and response to radiation: Implications for radiation therapy. Oncology 11: 349-352, 1997.
21. Dewey WC, Ling CC, and Meyn RE: Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol 33: 781-796, 1995.
22. Algan O, Stobbe CC, Helt AM, Hanks GE and Chapman JD: Radiation inactivation of human prostate cancer cells. The role of apoptosis. Radiat Res 146: 267-275, 1996.
23. Langley RE, Palayoor ST, Coleman CN and Bump EA: Radiation-induced apoptosis in F9 teratocarcionma cells. Int J Radiat Biol 65: 605-610, 1994.
24. Harmon BV, Takano YS, Winterford CM and Gobe GC: The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol 59: 489-501, 1991.
25. Sakaguchi Y, Stephens C, Makino M, Kaneko T, Strebel FR, Danhauser LL, Jenkens GN and Bull JM: Apoptosis in tumours and normal tissues induced by whole body hyperthermia in rats. Cancer Res 55: 5459-5464, 1995.
26. Sellins KS and Cohen J: Hyperthermia induces apoptosis in thymocytes. Radial Res 126: 88-95, 1991.
27. Harmon BV, Corder AM, Collins J, Gobe GC, Allen J, Allan DJ and Kerr JFR: Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat level. Int J Radiat Biol 58; 845-858, 1990.
28. Bichay TJ, Feeley MM, Raaphorst GP: A comparison of heat sensitivity, radiosensitivity and PLDR in four human melanoma cell lines. Melanoma Res 2: 63-69, 1992.